Danske Laegers Vaccinations Service
- Address
- Gladsaxevej 376, 1., 2860 Soeborg, Denmark
Virus Diseases and Preventive Vaccination Research
At Danske Laegers Vaccinations Service, the clinical trials focus on virus diseases and the prevention of common infections through vaccination. The research includes studies of influenza, RSV infection, and SARS-CoV-2 infection, with the goal of understanding how well vaccines protect older adults and other at-risk groups.
- Evaluating vaccine effectiveness for influenza prevention in older adults
- Studying protection against RSV-related respiratory tract disease
- Assessing vaccination impact on COVID-19 infection risk
This area of research is centered on improving real-world protection against respiratory viral illnesses and helping guide future vaccination strategies.
Skin and Connective Tissue Diseases and Age-Related Prevention Studies
The site also supports research in skin and connective tissue diseases, especially herpes zoster. These studies look beyond infection control and explore whether vaccination may influence broader health outcomes in older adults, including serious cardiovascular events and dementia.
- Investigating the prevention of herpes zoster in older adults
- Exploring possible effects on major adverse cardiovascular events
- Examining whether vaccination may affect the risk of dementia
This line of research reflects a growing interest in how vaccines may contribute to healthier aging and long-term disease prevention.
Adult Immunization Studies at a Vaccination Service Site
The clinical trial portfolio at this Denmark-based site is strongly centered on adult immunization, with a particular emphasis on older adults and people without major risk factors for severe disease. The studies are designed to compare vaccine performance and evaluate how well vaccination reduces hospitalizations and medically attended illness.
- Comparing protection between different influenza vaccines
- Measuring effectiveness of vaccines against respiratory infections
- Assessing whether vaccination can reduce serious health outcomes in later life
Overall, the research at Danske Laegers Vaccinations Service is aimed at strengthening evidence for vaccination programs and supporting better prevention of infectious disease in the community.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Gentofte Hospital2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 111 other sites in Denmark
Therapeutic Area Benchmark — Denmark
Select a therapeutic area to compare against other sites in Denmark.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Denmark
Market Share
Country: Denmark
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Danske Laegers Vaccinations Service
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Pragmatic Randomized Trial to Evaluate the Effectiveness of High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in Older Adults | Gentofte Hospital, Sanofi Pasteur | Phase III | Not Recruiting | Sep 2022 | Aug 2025 |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Elasomeran | 2 | Unknown | 2022-09-10 | 2025-12-11 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.